1 Min Read
Sept 13 (Reuters) - Moody’s says U.S. pharmaceutical research companies see strong revenue growth but profits will lag (Caryn Trokie, New York Ratings Unit)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.